Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.

Prostate 2008 May;68(7):740-7

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Background: Transcription factor 7-like 2 (TCF7L2) is a high mobility group-box containing protein that is a critical member of the Wnt/beta-catenin canonical signaling pathway. In addition to its recently recognized role in diabetes, aberrant TCF7L2 expression has been implicated in cancer through regulation of cell proliferation and apoptosis by c-MYC and cyclin D. It has been hypothesized that germline variants within the TCF7L2 gene previously associated with diabetes may affect cancer risk through the Wnt/beta-catenin signaling pathway. Specifically, the same risk allele of single nucleotide polymorphism (SNP) rs12255372 that is associated with diabetes (T allele) has recently been associated with an increased risk of breast cancer.

Methods: Here, we investigated associations between rs12255372 and prostate cancer risk among 1,457 cases and 1,351 controls from a population-based study.

Results: The variant TT genotype was not associated with overall prostate cancer risk. However, there was evidence that men homozygous for the variant T allele had an elevated relative risk of more aggressive prostate cancer, as defined by high Gleason score (OR = 1.7, 95% CI = 1.0-2.8) or regional/distant stage (OR = 1.7, 95% CI = 1.1-2.6) disease.

Conclusions: Our findings suggest that this variant in the TCF7L2 gene may be associated with risk of developing more clinically significant disease. These results need to be confirmed, but provide initial evidence that the TCF7L2 gene may alter risk of developing more aggressive prostate cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20732DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765224PMC
May 2008

Publication Analysis

Top Keywords

prostate cancer
20
tcf7l2 gene
16
cancer risk
16
risk
9
factor 7-like
8
7-like tcf7l2
8
transcription factor
8
aggressive prostate
8
associated diabetes
8
risk developing
8
gene associated
8
signaling pathway
8
cancer
7
tcf7l2
6
prostate
5
associated
5
risk 1457
4
1457 cases
4
rs12255372 prostate
4
associations rs12255372
4

References

(Supplied by CrossRef)

Jemal et al.
CA Cancer J Clin 2007

Steinberg et al.
Prostate 1990

Spitz et al.
J Urol 1991

Whittemore et al.
Am J Epidemiol 1995

Hayes et al.
Int J Cancer 1995

Ghadirian et al.
Int J Cancer 1997

Cerhan et al.
Cancer Epidemiol Biomarkers Prev 1999

Goldgar et al.
J Natl Cancer Inst 1994

Verhage et al.
Fam Cancer 2003

Ostrander et al.
Cancer Epidemiol Biomarkers Prev 2006

Edwards et al.
Am J Med Genet C Semin Med Genet 2003

Similar Publications